Cargando…
Aberrant PI3Kδ splice isoform as a potential biomarker and novel therapeutic target for endocrine cancers
INTRODUCTION: PI3K/AKT signaling pathway is upregulated in a broad spectrum of cancers. Among the class I PI3Ks (PI3Kδ/β/δ isoforms), PI3Kδ has been implicated in hematologic cancers and solid tumors. Alternative splicing is a post-transcriptional process for acquiring proteomic diversity in eukaryo...
Autores principales: | Ha, Siyoung, Gujrati, Himali, Wang, Bi-Dar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475954/ https://www.ncbi.nlm.nih.gov/pubmed/37670888 http://dx.doi.org/10.3389/fendo.2023.1190479 |
Ejemplares similares
-
Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms
por: Gujrati, Himali, et al.
Publicado: (2023) -
MicroRNA-mRNA Regulatory Network Mediates Activation of mTOR and VEGF Signaling in African American Prostate Cancer
por: Gujrati, Himali, et al.
Publicado: (2022) -
Downregulation of miR-99b-5p and Upregulation of Nuclear mTOR Cooperatively Promotes the Tumor Aggressiveness and Drug Resistance in African American Prostate Cancer
por: Gujrati, Himali, et al.
Publicado: (2022) -
Molecular Insight into Drug Resistance Mechanism Conferred by Aberrant PIK3CD Splice Variant in African American Prostate Cancer
por: Ha, Siyoung, et al.
Publicado: (2023) -
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
por: Robbins, Helen Louise, et al.
Publicado: (2016)